Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
PaperCitations, authors & open-access status
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 795 citations, 2017 year and bronze oa status.
795
Citations
2017
Year
bronze
OA Status